Details

Autor(en) / Beteiligte

• Hsu, Po-Chao
• Lee, Wen-Hsien
• Chen, Szu-Chia
• Tsai, Yi-Chun
• Chen, Ying-Chih
• Chu, Chun-Yuan
• Lin, Tsung-Hsien
• Voon, Wen-Chol
• Lai, Wen-Ter
• Sheu, Sheng-Hsiung
• Su, Ho-Ming

Titel

Using CHADS 2 and CHA 2 DS 2 -VASc scores for mortality prediction in patients with chronic kidney disease

Ist Teil von

• Scientific reports, 2020-11, Vol.10 (1), p.18942

Ort / Verlag

England

Erscheinungsjahr

2020

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Chronic kidney disease (CKD) is a public health issue and is associated with high morbidity and mortality. How to identify the high-risk CKD patients is very important to improve the long-term outcome. CHADS and CHA2DS2-VASc scores are clinically useful scores to evaluate the risk of stroke in patients with atrial fibrillation. However, there was no literature discussing about the usefulness of CHADS and CHA2DS2-VASc scores for cardiovascular (CV) and all-cause mortality prediction in CKD patients. This longitudinal study enrolled 437 patients with CKD. CHADS and CHA2DS2-VASc scores were calculated for each patient. CV and all-cause mortality data were collected for long-term outcome prediction. The median follow-up to mortality was 91 (25th-75th percentile: 59-101) months. There were 66 CV mortality and 165 all-cause mortality. In addition to age and heart rate, CHADS and CHA DS -VASc scores (both P value < 0.001) were significant predictors of CV and all-cause mortality in the multivariate analysis. Besides, in direct comparison of multivariate model, basic model + CHA DS -VASc score had a better additive predictive value for all-cause mortality than basic model + CHADS score (P = 0.031). In conclusion, our study showed both of CHADS and CHA DS -VASc scores were significant predictors for long-term CV and all-cause mortality in CKD patients and CHA DS -VASc score had a better predictive value than CHADS score for all-cause mortality in direct comparison of multivariate model. Therefore, using CHADS and CHA DS -VASc scores to screen CKD patients may be helpful in identifying the high-risk group with increased mortality.